Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ)
CNY 4.11
(0.0%)
CNY 4.11
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.96 Billion CNY | -28.8% |
| 2022 | 4.16 Billion CNY | 14.03% |
| 2021 | 3.65 Billion CNY | 31.11% |
| 2020 | 2.78 Billion CNY | 105.55% |
| 2019 | 1.35 Billion CNY | 49.43% |
| 2018 | 907.6 Million CNY | -1.31% |
| 2017 | 919.62 Million CNY | -26.0% |
| 2016 | 1.24 Billion CNY | 5.07% |
| 2015 | 1.18 Billion CNY | 72.69% |
| 2014 | 684.85 Million CNY | 32.62% |
| 2013 | 516.39 Million CNY | 24.38% |
| 2012 | 415.19 Million CNY | 16.15% |
| 2011 | 357.47 Million CNY | 96.26% |
| 2010 | 182.13 Million CNY | 35.02% |
| 2009 | 134.89 Million CNY | 47.22% |
| 2008 | 91.62 Million CNY | -19.47% |
| 2007 | 113.78 Million CNY | 34.91% |
| 2006 | 84.34 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 2.41 Billion CNY | -20.5% |
| 2024 Q1 | 3.08 Billion CNY | 3.95% |
| 2024 Q2 | 3.03 Billion CNY | -1.68% |
| 2023 FY | 2.96 Billion CNY | -28.8% |
| 2023 Q1 | 3.97 Billion CNY | -4.71% |
| 2023 Q4 | 2.96 Billion CNY | -15.15% |
| 2023 Q2 | 3.72 Billion CNY | -6.18% |
| 2023 Q3 | 3.49 Billion CNY | -6.14% |
| 2022 Q2 | 3.61 Billion CNY | 1.37% |
| 2022 Q3 | 3.67 Billion CNY | 1.72% |
| 2022 FY | 4.16 Billion CNY | 14.03% |
| 2022 Q1 | 3.56 Billion CNY | -2.45% |
| 2022 Q4 | 4.16 Billion CNY | 13.36% |
| 2021 Q4 | 3.65 Billion CNY | 2.35% |
| 2021 FY | 3.65 Billion CNY | 31.11% |
| 2021 Q1 | 2.96 Billion CNY | 6.29% |
| 2021 Q2 | 2.81 Billion CNY | -4.84% |
| 2021 Q3 | 3.57 Billion CNY | 26.65% |
| 2020 Q2 | 2.49 Billion CNY | 24.78% |
| 2020 FY | 2.78 Billion CNY | 105.55% |
| 2020 Q1 | 2 Billion CNY | 47.65% |
| 2020 Q3 | 2.65 Billion CNY | 6.27% |
| 2020 Q4 | 2.78 Billion CNY | 4.98% |
| 2019 Q2 | 1.15 Billion CNY | 25.93% |
| 2019 FY | 1.35 Billion CNY | 49.43% |
| 2019 Q4 | 1.35 Billion CNY | 22.05% |
| 2019 Q1 | 919.91 Million CNY | 1.36% |
| 2019 Q3 | 1.11 Billion CNY | -4.07% |
| 2018 Q2 | 983.24 Million CNY | 10.17% |
| 2018 Q3 | 809.33 Million CNY | -17.69% |
| 2018 FY | 907.6 Million CNY | -1.31% |
| 2018 Q1 | 892.45 Million CNY | -2.95% |
| 2018 Q4 | 907.6 Million CNY | 12.14% |
| 2017 Q1 | 1.15 Billion CNY | -6.95% |
| 2017 Q4 | 919.62 Million CNY | -0.55% |
| 2017 FY | 919.62 Million CNY | -26.0% |
| 2017 Q3 | 924.69 Million CNY | -7.93% |
| 2017 Q2 | 1 Billion CNY | -13.14% |
| 2016 Q3 | 1.41 Billion CNY | 39.6% |
| 2016 FY | 1.24 Billion CNY | 5.07% |
| 2016 Q4 | 1.24 Billion CNY | -12.23% |
| 2016 Q2 | 1.01 Billion CNY | -21.16% |
| 2016 Q1 | 1.28 Billion CNY | 8.77% |
| 2015 Q3 | 651.65 Million CNY | 2.04% |
| 2015 Q4 | 1.18 Billion CNY | 81.49% |
| 2015 FY | 1.18 Billion CNY | 72.69% |
| 2015 Q1 | 737.11 Million CNY | 7.63% |
| 2015 Q2 | 638.6 Million CNY | -13.36% |
| 2014 Q2 | 572.98 Million CNY | 12.14% |
| 2014 FY | 684.85 Million CNY | 32.62% |
| 2014 Q4 | 684.85 Million CNY | 2.59% |
| 2014 Q3 | 667.57 Million CNY | 16.51% |
| 2014 Q1 | 510.96 Million CNY | -1.05% |
| 2013 Q4 | 516.39 Million CNY | 18.95% |
| 2013 FY | 516.39 Million CNY | 24.38% |
| 2013 Q1 | 414.86 Million CNY | -0.08% |
| 2013 Q2 | 443.24 Million CNY | 6.84% |
| 2013 Q3 | 434.12 Million CNY | -2.06% |
| 2012 Q3 | 400.78 Million CNY | -5.57% |
| 2012 FY | 415.19 Million CNY | 16.15% |
| 2012 Q2 | 424.44 Million CNY | 19.25% |
| 2012 Q1 | 355.92 Million CNY | -0.43% |
| 2012 Q4 | 415.19 Million CNY | 3.6% |
| 2011 Q1 | 196.61 Million CNY | 7.95% |
| 2011 Q4 | 357.47 Million CNY | 19.06% |
| 2011 Q2 | 192.25 Million CNY | -2.22% |
| 2011 FY | 357.47 Million CNY | 96.26% |
| 2011 Q3 | 300.24 Million CNY | 56.17% |
| 2010 Q1 | 107.95 Million CNY | -19.98% |
| 2010 FY | 182.13 Million CNY | 35.02% |
| 2010 Q4 | 182.13 Million CNY | 36.21% |
| 2010 Q3 | 133.71 Million CNY | -7.84% |
| 2010 Q2 | 145.09 Million CNY | 34.41% |
| 2009 FY | 134.89 Million CNY | 47.22% |
| 2009 Q2 | 94.15 Million CNY | 0.0% |
| 2009 Q4 | 134.89 Million CNY | 38.7% |
| 2009 Q3 | 97.25 Million CNY | 3.29% |
| 2008 FY | 91.62 Million CNY | -19.47% |
| 2008 Q4 | 91.62 Million CNY | 0.0% |
| 2007 FY | 113.78 Million CNY | 34.91% |
| 2006 FY | 84.34 Million CNY | 0.0% |